News

PCa17: What to expect in future prostate cancer management

The number of promising biomarkers at different molecular levels are increasing, accompanied by numerous testing in the market, but cancer experts say independent and prospective validation is crucial to help the medical community eventually provide optimal care to cancer...

PCa17: Interactive, compact meeting opens in Vienna

Challenges in diagnosis, staging and patient selection were among the issues taken up in the first plenary session of the EAU Update on Prostate Cancer (PCa17) opened in Vienna today. With more than 300 participants including faculty and exhibitors,...

EMUC17: Using biomarkers in decision-making for RCC treatment

Renal cell carcinomas are among the most lethal in urological malignancies prompting doctors to search for tools such as biomarkers and other molecular techniques to distinguish aggressive diseases. With new research outcomes, physicians are hopeful that diagnosis and therapy...
Click to go to the course

ESU introduces new urolithiasis e-course in collaboration with EULIS

The EAU Education Online course Introduction to Upper Urinary Tract Endoscopy for Stones is the latest installment to a series of highly-informative e-courses designed to equip junior urologists and to refresh the more experienced with the latest in ureteroscopic stone...

Discovery Award for Israeli bio-chip testing technology

An Israeli testing technology that rapidly identifies bacterial infection in hours instead of days has won the Discovery Award, a financing grant from the United Kingdom that will enable the team to further test and expand the use of...